Revance Therapeutics, Inc. - 761330109
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q4 2024
· Q3 2024
Value (USD)
Total reported value ($000)
$181.3M
QoQ value delta ($000)
-$146.5M
(-44.69%)
Implied price effect (QoQ)
-41.41%
Shares
Total shares
59,664,718
QoQ shares delta
-3,535,403
(-5.59%)
Total shares held by funds (by quarter)
Top holders (Q4 2024)
Top 25 only
Full list
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| BlackRock, Inc. | 26,136 | 8,597,418 | 0.0% |
| VANGUARD GROUP INC | 17,100 | 5,625,091 | 0.0% |
| FIL Ltd | 12,756 | 4,196,095 | 0.01% |
| ALLIANCEBERNSTEIN L.P. | 10,631 | 3,497,112 | 0.0% |
| Squarepoint Ops LLC | 9,659 | 3,177,543 | 0.01% |
| Magnetar Financial LLC | 7,771 | 2,556,345 | 0.18% |
| STATE STREET CORP | 7,414 | 2,439,140 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 6,986 | 2,297,582 | 0.0% |
| BOOTHBAY FUND MANAGEMENT, LLC | 6,197 | 2,038,677 | 0.15% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,027 | 1,653,689 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 4,716 | 1,551,372 | 0.0% |
| UBS Group AG | 4,508 | 1,483,040 | 0.0% |
| AQR Arbitrage LLC | 4,295 | 1,413,103 | 0.09% |
| D. E. Shaw & Co., Inc. | 4,247 | 1,397,343 | 0.0% |
| Qube Research & Technologies Ltd | 4,038 | 1,328,525 | 0.01% |
| JPMORGAN CHASE & CO | 3,948 | 1,298,822 | 0.0% |
| GABELLI FUNDS LLC | 3,837 | 1,262,487 | 0.03% |
| FRANKLIN RESOURCES INC | 3,530 | 1,161,382 | 0.0% |
| NORTHERN TRUST CORP | 3,012 | 991,043 | 0.0% |
| MORGAN STANLEY | 2,716 | 893,686 | 0.0% |
| GOLDMAN SACHS GROUP INC | 2,471 | 812,927 | 0.0% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,423 | 797,299 | 0.0% |
| CITADEL ADVISORS LLC | 2,371 | 780,118 | 0.0% |
| LMR Partners LLP | 1,359 | 447,207 | 0.01% |
| Man Group plc | 1,348 | 443,544 | 0.0% |